Insight Pharmaceuticals Corp — Form D

Insight Pharmaceuticals Corp of LANGHORNE, PA, a company, filed a Form D exempt-offering notice with the SEC on 2009-07-01. The offering totals $32.3M, of which $32.3M was reported sold. Industry: Other.

Offering

Issuer

Officers, directors & promoters (22)

NameRoleLocation
Craig HilleDirectorWashington, DC
Robert MonkDirectorReston, VA
MARK POFFDirectorSAN FRANCISCO, CA
Mickael TukdarianDirectorLanghorne, PA
MARK POFFExecutive OfficerSAN FRANCISCO, CA
Joseph SuprenukExecutive OfficerLanghorne, PA
Kipp deVeerDirectorNew York, NY
C. MORRIS STOUTDirectorSAN FRANCISCO, CA
C. MORRIS STOUTExecutive OfficerSAN FRANCISCO, CA
DANIEL C REESEDirectorSAN FRANCISCO, CA
DANIEL C REESEExecutive OfficerSAN FRANCISCO, CA
Scott C EmersonDirectorTrevose, PA
Mark C PoffDirectorSan Francisco, CA
Mark C PoffExecutive OfficerSan Francisco, CA
Gary DowningDirectorLanghorne, PA
Gary DowningExecutive OfficerLanghorne, PA
Dennis KinseyExecutive OfficerLanghorne, PA
James BerwickExecutive OfficerLanghorne, PA
Mickael TukdarianExecutive OfficerLanghorne, PA
Michael C SmithDirectorLanghorne, PA
Michael C WesthusingDirectorLanghorne, PA
Kipp C DeVeerDirectorLanghorne, PA

Other filings by this issuer (2)

FiledFormOfferingSold
2011-08-29D$65.0M$65.0M
2011-03-14D$5.6M$5.6M

More